These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 851383)

  • 21. Photogenerated reagents for membrane labeling. 2. Phenylcarbene and adamantylidene formed within the lipid bilayer.
    Bayley H; Knowles JR
    Biochemistry; 1978 Jun; 17(12):2420-3. PubMed ID: 678520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [1-adamantanecarboxamide derivatives with potential antiviral and antineoplastic activity].
    Fenech G; Vigorita MG; Ficarra P; Ficarra R
    Boll Chim Farm; 1979 Feb; 118(2):78-87. PubMed ID: 454536
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antimycotic agents. 7. Nuclear substituted N-(1-adamantyl)-N'-phenylthiourea derivatives].
    Kreutzberger A; Tantawy A
    Arch Pharm (Weinheim); 1978 Sep; 311(9):770-4. PubMed ID: 708208
    [No Abstract]   [Full Text] [Related]  

  • 24. Biological activity of a hypobetalipoproteinemic agent.
    Day CE; Schurr PE; Heyd WE; Lednicer D
    Adv Exp Med Biol; 1976; 67(00):231-249. PubMed ID: 179296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Adamantyl- and 2-adamantylidene-2-ethylamines.
    Mariani E; Schenone P
    Farmaco Sci; 1976 Apr; 31(4):272-6. PubMed ID: 939326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular assembly and encapsulation directed by hydrogen-bonding preferences and the filling of space.
    Martín T; Obst U; Rebek J
    Science; 1998 Sep; 281(5384):1842-5. PubMed ID: 9743495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypobetalipoproteinemic agents. 2. Compounds related to 4-(1-adamantyloxy)aniline.
    Lednicer D; Heyd WE; Emmert DE; TenBrink RE; Schurr PE; Day CE
    J Med Chem; 1979 Jan; 22(1):69-77. PubMed ID: 218007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Synthesis of 1,3-disubstituted adamantanes (author's transl)].
    Fischer W; Grob CA; Katayama H
    Helv Chim Acta; 1976 Sep; 59(6):1949-62. PubMed ID: 1017951
    [No Abstract]   [Full Text] [Related]  

  • 29. Determination of the partition coefficients of adamantyl derivatives by reversed phase TLC and HPLC.
    Tsantili-Kakoulidou A; Antoniadou-Vyza A
    Prog Clin Biol Res; 1989; 291():71-4. PubMed ID: 2726890
    [No Abstract]   [Full Text] [Related]  

  • 30. General synthesis of potentially antiviral alpha-adamantyl carbonyl compounds.
    Reetz MT; Maier WF; Schwellnus K; Chatziiosifidis I
    Angew Chem Int Ed Engl; 1979 Jan; 18(1):72. PubMed ID: 105650
    [No Abstract]   [Full Text] [Related]  

  • 31. Phosphorus-nitrogen compounds. 21. Murine oncolytic and antifertility effect of adamantylaziridine compounds.
    Cates LA; Cramer MB; Williams L
    J Med Chem; 1978 Jan; 21(1):143-6. PubMed ID: 619145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antiviral agents, XI: Nucleophilic substitutions and additions with 2-aminoadamantane (author's transl)].
    Kreutzberger A; Schröders HH
    Arch Pharm (Weinheim); 1976 Nov; 309(11):919-25. PubMed ID: 1016004
    [No Abstract]   [Full Text] [Related]  

  • 33. [Determination of the purity and stability of diadonium].
    Stepanenko OB; Merinova SV; Naumova NV
    Farmatsiia; 1978; 27(6):24-8. PubMed ID: 729809
    [No Abstract]   [Full Text] [Related]  

  • 34. Adamantane and protoadamantanealkanamines as potential anti-Parkinson agents.
    Chakrabarti JK; Hotten TM; Sutton S; Tupper DE
    J Med Chem; 1976 Jul; 19(7):967-9. PubMed ID: 940116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The pharmacokinetics of adamantanes].
    Sergeeva SA; Krasnykh LM
    Eksp Klin Farmakol; 1994; 57(3):69-74. PubMed ID: 8049625
    [No Abstract]   [Full Text] [Related]  

  • 36. trans-thionate derivatives of Pt(II) and Pd(II) with water-soluble phosphane PTA and DAPTA ligands: antiproliferative activity against human ovarian cancer cell lines.
    Guerrero E; Miranda S; Lüttenberg S; Fröhlich N; Koenen JM; Mohr F; Cerrada E; Laguna M; Mendía A
    Inorg Chem; 2013 Jun; 52(11):6635-47. PubMed ID: 23692403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiviral agents. 6. Variation of substituents in the series of N'-substituted N-(adamantyl-(1))-thioureas].
    Kreutzberger A; Schröders HH
    Arch Pharm (Weinheim); 1975 Oct; 308(10):748-54. PubMed ID: 1200790
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sensitivity of influenza virus A/New Jersey/8/76 to rimantadine].
    Pushkarskaia NL; Blinova VK; Podcherniaeva RIa; Obrosova-Serova NP; Galegov GA
    Vopr Virusol; 1977; (3):369-71. PubMed ID: 906446
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of rimantadine for the treatment and prevention of influenza in the polyclinic].
    Smagulova EG; Krylov VF; Alekseeva AA; Demidova SA; Kuptsevich TP
    Sov Med; 1979 May; (5):90-3. PubMed ID: 377516
    [No Abstract]   [Full Text] [Related]  

  • 40. Adamantylamphetamines: evaluation of their activity on the central nervous system.
    De Angelis L; Traversa U; Vertua R
    Farmaco Prat; 1976 May; 31(5):227-37. PubMed ID: 1269731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.